Histiocytosis, Sinus: Clinical Trials

9 trials for Histiocytosis, Sinus, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 recruiting, 2 unknown. 4 Phase 2, 1 Early Phase 1, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 24Recruiting 3, Unknown 1
Early Phase 11Recruiting 1
Phase 41Unknown 1

Follow Histiocytosis, Sinus: new trials by email Literature Review of Histiocytosis, Sinus trials Research Report on Histiocytosis, Sinus

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of the RD Regimen(Lenalidomide, Dexamethasone) for Rosai-Dorfman Disease
Lenalidomide, Dexamethasone - Rosai-Dorfman Disease
Phase 2RecruitingCancer Institute and Hospital, Chinese Academy of Medical Sciences402025-04-122025-09-22
Mirdametinib in Histiocytic Disorders
Mirdametinib - Langerhans Cell Histiocytosis (LCH), Juvenile Xanthogranuloma (JXG)
Phase 2RecruitingChildren's Hospital Medical Center, Cincinnati402024-02-052026-09-21
Histiocytic Disorder Follow-up Study
Histiocytosis, Langerhans Cell Histiocytosis
RecruitingUniversity of Alabama at Birmingham60002022-09-012026-06-12
In-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PET
[68Ga]-Pentixafor - Non-Hodgkin Lymphoma, Multiple Myeloma
Early Phase 1RecruitingMemorial Sloan Kettering Cancer Center302021-10-012026-02-05
Lenalidomide and Dexamethasone for Rosai-Dorfman Disease
lenalidomide and dexamethasone - Rosai-Dorfman Disease
Phase 2UnknownPeking Union Medical College Hospital162021-06-082021-06-16
Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders
Cobimetinib - Langerhan's Cell Histiocytosis, Juvenile Xanthogranuloma
Phase 2RecruitingCarl Allen902021-04-192026-10-26
Registry for Patients With Erdheim-Chester Disease and Other Histiocytoses
Erdheim-Chester Disease
RecruitingMemorial Sloan Kettering Cancer Center5002017-10-262026-01-08
International Rare Histiocytic Disorders Registry (IRHDR)
Registry study - Rare Histiocytic Disorders (RHDs), Erdheim-Chester Disease (ECD)
RecruitingThe Hospital for Sick Children4002014-10-012025-06-24
Central China Rosai-Dorfman Disease Registry
Mycophenolate mofetil combined with oral prednisone - Rosai-Dorfman Disease, Langerhans Cell Histiocytosis
Phase 4UnknownTongji Hospital202011-10-012022-03-17

Narrower conditions

Erdheim-Chester Disease (5)  ·  Histiocytosis, Langerhans-Cell (5)  ·  Histiocytic Sarcoma (2)  ·  Xanthogranuloma, Juvenile (2)  ·  Histiocytic Disorders, Malignant (1)  ·  Histiocytosis (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Multiple Myeloma (1)  ·  Necrobiotic Xanthogranuloma (1)  ·  Neoplasms, Second Primary (1)

Broader conditions

Hemic and Lymphatic Diseases (9)  ·  Histiocytosis, Non-Langerhans-Cell (9)  ·  Lymphatic Diseases (9)  ·  Histiocytosis (8)  ·  Lung Diseases (5)  ·  Lung Diseases, Interstitial (5)  ·  Respiratory Tract Diseases (5)  ·  Neoplasms (3)  ·  Neoplasms by Histologic Type (3)  ·  Skin Diseases (3)  ·  Skin and Connective Tissue Diseases (3)  ·  Lymphoproliferative Disorders (2)  ·  Blood Protein Disorders (1)  ·  Cardiovascular Diseases (1)  ·  Collagen Diseases (1)

Interventions

Dexamethasone (2)  ·  Lenalidomide (2)  ·  68Ga-pentixafor (1)  ·  Prednisone (1)  ·  cobimetinib (1)  ·  mirdametinib (1)

Sponsors

Memorial Sloan Kettering Cancer Center (2)  ·  Cancer Institute and Hospital, Chinese Academy of Medical Sciences (1)  ·  Carl Allen (1)  ·  Children's Hospital Medical Center, Cincinnati (1)  ·  Peking Union Medical College Hospital (1)  ·  The Hospital for Sick Children (1)  ·  Tongji Hospital (1)  ·  University of Alabama at Birmingham (1)

Countries

United States (6)  ·  China (3)  ·  Argentina (1)  ·  Canada (1)  ·  Czechia (1)  ·  Germany (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Poland (1)  ·  Spain (1)

Top investigators

Allison Bartlett, MD (1)  ·  Anton Nosov, MD (1)  ·  Ashish Kumar, MD, PhD (1)  ·  Carl E Allen, MD, PhD (1)  ·  Dao-bin Zhou (1)  ·  Eli Diamond, MD (1)  ·  Gaurav Goyal, MD (1)  ·  Oussama Abla, MD (1)  ·  Xinxin XX Cao, doctor (1)

Results publications

PMID 33057928, PMID 39022796, PMID 39626273